Bon Natural Life Ltd (BON)

NASD · Basic Materials · Specialty Chemicals · China

Bon Natural Life Ltd is a micro cap company (market value under $300 million) in the Specialty Chemicals industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Bon Natural Life Ltd stock.

Our verdict on BON

Undervalued: intrinsic value $4.18 per share, market price $1.14, margin of safety 72.7% (as of 2026-10-30).

Its through-the-cycle earnings (19.4% median margin), capitalised at 7.4% with no growth, values the shares at $4.18; the price of $1.14 is 73% below that value.

Leak Score: 58/100 on 9 of 12 signals (Weak Signal).

Browse

Peers in Specialty Chemicals

All 62 Specialty Chemicals stocks

Is BON undervalued or overvalued?

BON is undervalued (as of the 2026-10-30 close). Its through-the-cycle earnings (19.4% median margin), capitalised at 7.4% with no growth, values the shares at $4.18; the price of $1.14 is 73% below that value.

What is the intrinsic value of BON?

$4.18 per share (as of the 2026-10-30 close), against a market price of $1.14. That is a margin of safety of 72.7%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Bon Natural Life Ltd's Leak Score?

58 out of 100, which we rate "Weak Signal", on 9 of 12 value investing signals.